Skip to content ↓

Resources: News

Categories:
All
Events
Industry Insights
News
Webinars
White Papers

Latest in News

Using Real-World Evidence to Optimize Clinical Trials

Using Real-World Evidence to Optimize Clinical Trials

This pivotal new paper, which you can download HERE, describes how biopharmaceutical companies can better leverage existing real-world data (RWD) to improve the costs and efficiencies of R&D and accelerate the timelines of clinical trials without compromising the quality of evidence development, and instead greatly enhance trial feasibility, implementation,…

SHYFT Debuts New Lumen UI, its Latest Analytics and Data Visualization Platform

SHYFT Debuts New Lumen UI, its Latest Analytics and Data Visualization Platform

WALTHAM, MA – April 30, 2018 – SHYFT Analytics, the leading cloud data analytics provider for life sciences, today announced the launch of Lumen, its newest data visualization platform. Developed for both clinical and commercial teams, Lumen uses advanced data-driven analytical and visual information design to empower users to…

SHYFT Announces Promotion of Priya Sapra to Chief Operating Officer

SHYFT Announces Promotion of Priya Sapra to Chief Operating Officer

SHYFT Analytics, the leading data and analytics cloud for life sciences, today announced that Priya (Bhargava) Sapra has been named Chief Operating Officer and Chief Product Officer. Priya is part of SHYFT’s executive team and oversees Product Innovation for SHYFT’s award winning platform. Her role will expand to include…

SHYFT Selected as a Top 100 Digital Tech Company in Boston

SHYFT Selected as a Top 100 Digital Tech Company in Boston

SHYFT is honored to be named one of the top 100 digital tech companies in Boston today, not only because we’re a tech company being listed alongside giants like MathWorks and TripAdvisor, but because we play in a sector that has been at the heart of…

Six New Companies Select SHYFT to Launch Their Specialty and Rare Disease Brands

Six New Companies Select SHYFT to Launch Their Specialty and Rare Disease Brands

SHYFT Analytics, the leading data and analytics cloud for life sciences, today announced that in the last quarter, six biopharma companies have chosen to launch their new therapies using the SHYFT Platform. The number of SHYFT Launch customers has increased 50% year over year propelled by the company’s uniquely…

Pfizer’s Former Head of Real World Data and Analytics, Marc Berger, to Lead SHYFT Product Advisory Board

Pfizer’s Former Head of Real World Data and Analytics, Marc Berger, to Lead SHYFT Product Advisory Board

Waltham, MA – September 12, 2017 – SHYFT Analytics, the leading analytics cloud for life sciences, today announced the addition of Marc Berger, MD to head its Real World Evidence Product Advisory Board. Dr. Berger, the former Vice President of Real World Data and Analytics at Pfizer, joins SHYFT to help…

SHYFT Announces Strategic Investment From Optum

SHYFT Announces Strategic Investment From Optum

Optum investment closes out $20 million Series B funding that includes McKesson and Medidata following SHYFT’s 80% growth in SaaS Subscriptions in 2016 Investment advances SHYFT’s health care cloud analytics platform in areas of Real World Evidence, Specialty Pharma, Oncology and Rare Disease Waltham, MA – March 29, 2017 – SHYFT…

SHYFT Analytics Appoints Joseph Tyers to Chief Revenue Officer

SHYFT Analytics Appoints Joseph Tyers to Chief Revenue Officer

Life Sciences Software Executive to Lead Commercial Team Waltham, MA – January 24, 2017 – SHYFT Analytics, the leader in Cloud Analytics Solutions for global life sciences, today announced that Joseph Tyers has been named Chief Revenue Officer. An industry veteran and former Senior Vice President of Sales, Value Management and Commercial…

Medidata and SHYFT Analytics Form Commercial Partnership

Medidata and SHYFT Analytics Form Commercial Partnership

Technology Leaders Join Forces to Bring Real World Evidence Data Analytics to Drug Development NEW YORK, N.Y. and WALTHAM, M.A. – September 6, 2016 – Medidata (NASDAQ: MDSO) and SHYFT Analytics (SHYFT) today announced a strategic commercial partnership to increase access to healthcare data analytics in clinical trials. The partnership will enable…

SHYFT Analytics Raises 12.5 Million in New Funding from Global Healthcare and Technology Leaders, led by McKesson Ventures and Medidata Solutions

SHYFT Analytics Raises 12.5 Million in New Funding from Global Healthcare and Technology Leaders, led by McKesson Ventures and Medidata Solutions

Strategic Investments to Accelerate Growth Fueled by Demand for Healthcare Analytics Waltham, MA – August 30, 2016 – SHYFT Analytics, a leader in cloud data and analytics for the global life sciences industry, today announced the company has secured an initial $12.5 million in Series B funding. SHYFT Management opted for an…